Home/Filings/4/0001209191-22-035554
4//SEC Filing

Wong Hing C 4

Accession 0001209191-22-035554

CIK 0001828673other

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 5:59 PM ET

Size

6.4 KB

Accession

0001209191-22-035554

Insider Transaction Report

Form 4
Period: 2022-06-07
Wong Hing C
DirectorChief Executive Officer10% Owner
Transactions
  • Purchase

    Common Stock

    2022-06-07$2.31/sh+1,000$2,31015,282,948 total
  • Purchase

    Common Stock

    2022-06-09$2.25/sh+2,000$4,49015,284,948 total
Footnotes (1)
  • [F1]The range of prices for the shares of Common Stock is from $2.24 to $2.25. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.

Issuer

HCW Biologics Inc.

CIK 0001828673

Entity typeother

Related Parties

1
  • filerCIK 0001866258

Filing Metadata

Form type
4
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 5:59 PM ET
Size
6.4 KB